Typically, you would begin a miRNA expression analysis with the same steps outlined in the Importing Affymetrix CEL files section of the Gene Expression tutorial. Here, the data has already been imported and attributes added. 

To being our analysis, we will open the miRNA Expression workflow. 

The miRNA Expression workflow provides a series of steps for analyzing miRNA expression data and integrating it with gene expression data (Figure 1).

 

Exploratory data analysis

Principal Components Analysis (PCA) is an excellent method to visualize similarities and differences between the samples in a data set. PCA can be invoked through a workflow, by selecting  from the main command bar, or by selecting Scatter Plot from the View section of the main toolbar. We will use a workflow. 

This is the probe intensities spreadsheet for the miRNA expression data (Figure 2). Each row is a sample; columns 7 to 9 give attribute information about each sample including tissue, replicate number, and scan date, while columns 10 on give prove intensities values. 

 

 

A new tab will open showing a PCA scatter plot (Figure 3).

 

In this PCA scatter plot, each point represents a sample in the spreadsheet. Points that are close together in the plot are more similar, while points that are far apart in the plot are more dissimilar. 

To better view the data, we can rotate the plot.

Rotating the plot allows us to look for outliers in the data on each of the three principal components (PC1-3). The percentage of the total variation explained by each PC is listed by its axis label. The chart label shows the sum percentage of the total variation explained by the displayed PCs. 

Here, we can see that the brain and heart samples are well separated across PC1, which is expected. 

For more information about customizing the plot, please see Exploring the data set with PCA from the Gene Expression with Batch Effect tutorial. 

Detecting differentially expressed miRNAs

Next, we will identify miRNAs that are differentially expressed between brain and heart tissues. 

The ANOVA dialog (Figure 4) allows us to configure the comparisons we want to make between samples and groups within the data set. 

 

The Contrasts... button will now be available to select. 

The Configure ANOVA dialog (Figure 5) is used to set up contrasts. Contrasts are the comparisons between groups and are where experimental questions can be asked. In this study, we are asking what miRNAs are differentially expressed between heart and brain tissue. 

 

This contrast (Figure 6) will compare expression of miRNAs in brain samples to expression in heart samples with brain as the numerator and heart as the denominator for fold-change calculations. 

 

The Contrasts... button should now read Contrasts Included. 

An ANOVA Results sheet, ANOVAResults, will be created as a child spreadsheet of Affy_miR_BrainHeart_intensities (Figure 7). In this spreadsheet, each row represents a probe set and the columns represent the computation results for that probe set. Although not synonymous, probe set and gene will be treated as synonyms in this tutorial for convenience. By default, the genes are sorted in ascending order by the p-value of the first categorical factor, which, in this case, is Tissue. This means the most significant differentially expressed miRNAs between the brain and heart (up-regulated and donw-regulated) are at the top of the spreadsheet. 

 

You may explore what is known about any listed miRNA using external databases TargetScan, miRBase, microRNA.org, or miR2Disease, by right-clicking a row header, selecting Find miRNA in... and choosing one of the external databases. This will open a web page in your default web browser and requires your computer be connected to the internet. 

For more information about AVOVA in Partek Genomics Suite, see Identifying differentially expressed genes using ANOVA

Creating a list of miRNAs of interest

The ANOVA results spreadsheet includes every miRNA on the array for a total of 7815 miRNAs. However, many of these miRNAs are not significantly differentially expressed between brain and heart and, thus, are not of interest. Next, we will create a filtered list of significantly differentially expressed miRNAs.

The List Manager dialog will open (Figure 8). 

By default, the fold-change and significance thresholds are set to > 2, < -2 and p-value with FDR < 0.05. These defaults are appropriate for this tutorial so we will leave them in place.

 

A new spreadsheet, brain vs. heart will be created as a child spreadsheet of Affy_miR_BrainHeart (Figure 9).

 

To view the miRNAs with the largest difference between tissues, we can sort by fold-change.

The top 33 miRNAs we see (Figure 10) are all miR-124 from different species. The miRNA miR-124 is the most abundant miRNA in neuronal cells so this finding is expected. The multiple species versions of miR-124 are present because Affymetrix GeneChip miRNA arrays provide comprehensive coverage of miRNAs from multiple organisms including human, mouse, rat, canine, monkey, and many more on a single chip. The miRNAs from these different species are highly homologous so probes targeting miRNAs from other species will hybridize with human miRNAs. Therefore, we need to filter the list of miRNAs to include only human miRNAs.

 

To do this, we need to add a new annotation column containing species information for each probe.

The table now includes a column 3. Species Scientific Name with the species name of each miRNA. We can now filter to include only human miRNAs.

 

The search should find and select 251 miRNAs. 

The spreadsheet will now include only the 251 miRNAs from human (Figure 13). The first row is still miR-124 with a fold change of 4087.94. The black and gold bar on the right-hand side of the spreadsheet indicates the fraction of rows that have been filtered. To retain this filtered list, we can create a new spreadsheet. 

 

Cloning a spreadsheet while a filter is applied copies only the included rows/columns. 

The new spreadsheet includes only the 251 human miRNAs that are significantly differentially expressed between brain and heart tissue (Figure 14). 

 

The next step in our analysis will be integrating miRNA and gene expression data.